Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 0.91 -0.03 (3.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.94 | 52 Week High | $0.92 | |||
| Open | $0.94 | 52 Week Low | $0.32 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.91 | EPS | $-0.18 | |||
| Volume | 17,116 | |||||
